These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31281686)

  • 1. Successful Management of Immune Thrombocytopenia Presenting with Lethal Alveolar Hemorrhage.
    Nagaharu K; Masuya M; Kawakami K; Katayama N
    Case Rep Hematol; 2019; 2019():5170282. PubMed ID: 31281686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
    Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage.
    Gellens R; Habchi S; Freppel S; Couret D; Iacobelli S
    Front Neurol; 2017; 8():737. PubMed ID: 30210422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine.
    Okazuka K; Masuko M; Matsuo Y; Miyakoshi S; Tanaka T; Kozakai T; Kobayashi H; Fuse K; Shibasaki Y; Moriyama M; Takizawa J; Fuse I; Toba K; Furukawa T
    Intern Med; 2013; 52(11):1239-42. PubMed ID: 23728563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.
    Choe MJ; Packer CD
    Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
    J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis.
    Lame D; Pianelli M; Kordasti S; Morsia E; Olivieri A; Poloni A
    Hematol Rep; 2024 Mar; 16(1):125-131. PubMed ID: 38534883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.
    Rosa María RN; Laura RL; Ángeles PB; Laura LB
    Platelets; 2020; 31(3):403-406. PubMed ID: 31116059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.
    Perdomo J
    Immunotargets Ther; 2016; 5():1-7. PubMed ID: 27529057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.
    Gilbert MM; Grimes AB; Kim TO; Despotovic JM
    Patient Prefer Adherence; 2020; 14():1237-1250. PubMed ID: 32801654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.
    Neunert CE; Rose MJ
    Blood Adv; 2019 Jun; 3(12):1907-1915. PubMed ID: 31239245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.
    Buchbinder D; Nugent D; Hsieh L
    Drug Des Devel Ther; 2017; 11():1055-1063. PubMed ID: 28408804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim.
    Al-Samkari H; Van Cott EM; Kuter DJ
    Ann Hematol; 2019 Mar; 98(3):581-588. PubMed ID: 30446804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of a Romiplostim Biosimilar in Chronic Refractory Immune Thrombocytopenic Purpura (ITP) Patients.
    Singh I; Swetha RK; Patel R; Dahiya M; Jose V;
    Indian J Hematol Blood Transfus; 2022 Jan; 38(1):111-121. PubMed ID: 35125719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.